Sangamo Therapeutics (SGMO)

Sangamo Therapeutics

SGMO

#7763

Rank

€0.18 B

Marketcap

🇺🇸 USA

Country

0,87 €

Share price

6.69%

Change (1 day)

9.99%

Change (1 year)

💊 Pharmaceuticals 🧬 Biotech 🧬 Genomics 🧬 Gene therapy

Sangamo Therapeutics - P/B ratio (from 2001 to 2024)

P/B ratio by year

Year	P/B ratio	Change
2024-12-31	N/A	-100%
2023-12-31	1.16	-33.37%
2022-12-31	1.74	-40.07%
2021-12-31	2.91	-34.41%
2020-12-31	4.44	97.84%
2019-12-31	2.24	-29.78%
2018-12-31	3.19	-56.7%
2017-12-31	7.38	366.44%
2016-12-31	1.58	-52.62%
2015-12-31	3.34	-34.34%
2014-12-31	5.08	-28.44%
2013-12-31	7.10	44.56%
2012-12-31	4.91	164.22%
2011-12-31	1.86	-65.49%
2010-12-31	5.39	45.24%
2009-12-31	3.71	44.14%
2008-12-31	2.57	-64.63%
2007-12-31	7.28	53.27%
2006-12-31	4.75	45.76%
2005-12-31	3.26	-30.43%
2004-12-31	4.68	53.23%
2003-12-31	3.06	122.63%
2002-12-31	1.37

P/B ratio for similar companies or competitors

Company	P/B ratio	differencediff.	Country
Gilead Sciences GILD	5.74	-25.12%	🇺🇸 USA
Alnylam Pharmaceuticals ALNY	< -1000	-150,037.92%	🇺🇸 USA
Amgen AMGN	30.7	300.85%	🇺🇸 USA
Biogen BIIB	1.82	-76.23%	🇺🇸 USA
Dow DOW	1.93	-74.85%	🇺🇸 USA
Johnson & Johnson JNJ	5.54	-27.65%	🇺🇸 USA
BioMarin Pharmaceutical BMRN	2.54	-66.82%	🇺🇸 USA
Merck MRK	6.81	-11.15%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is receiving financial compensation for Delta App installs.
CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Sangamo Therapeutics (SGMO) - P/B ratio

P/B ratio as of September 2024 : 7.66